Capital Insight Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Capital Insight Partners's LLY Position: Q1 2026 in Review
Capital Insight Partners sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,177 shares — an estimated $1.26M sold.
Capital Insight Partners first reported a position in LLY in Q1 2021 and held it in 20 quarters. The position peaked at $1.37M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Capital Insight Partners reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
- Capital Insight Partners sold 1,177 Eli Lilly shares in Q1 2026, an estimated $1.26M.
- Capital Insight Partners first reported a position in Eli Lilly in Q1 2021 and held it in 20 quarters.
- Capital Insight Partners's Eli Lilly position peaked at $1.37M in Q2 2024.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Capital Insight Partners's 13F filing for Q1 2026.